COMPANY
Novo Nordisk Pharma, Inc.
Novo Nordisk Pharma, Inc.: US labeler for Insulin degludec, as stated by public registers.
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Insulin degludec | Insulin Degludec, BLA Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.